4-((2,5-Dichloropyrimidin-4-yl)amino)benzo[c][1,2]oxaborol-1(3H)-ol

Catalog No. :
ACSLDB179
CAS No. :
2088570-59-4
Molecular Formula :
C11H8BCl2N3O2
Molecular Weight :
295.92

IUPAC Name:4-((2,5-dichloropyrimidin-4-yl)amino)benzo[c][1,2]oxaborol-1(3H)-ol

4-((2,5-Dichloropyrimidin-4-yl)amino)benzo[c][1,2]oxaborol-1(3H)-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$432.00Login to see priceInquiryInquiry
1g98%$1081.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((2,5-Dichloropyrimidin-4-yl)amino)benzo[c][1,2]oxaborol-1(3H)-ol
IUPAC Name4-((2,5-dichloropyrimidin-4-yl)amino)benzo[c][1,2]oxaborol-1(3H)-ol
MDL No.MFCD32644146
Molecular FormulaC11H8BCl2N3O2
Molecular Weight295.92
SMILESOB1OCC2=C(C=CC=C12)NC3=NC(Cl)=NC=C3Cl
InChI KeyHJNSHRMJCGIZBD-UHFFFAOYSA-N
Synonym2,5-Dichloro-N-(1-hydroxy-3H-2,1-benzoxaborol-4-yl)pyrimidin-4-amine;4-Pyrimidinamine, 2,5-dichloro-N-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-4-yl)-
CAS No.2088570-59-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACSLDB179 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBZA486 route compound structure diagram
    ACLBZA4861285533-08-5 In Stock
  4. Then
  5. ACSLDB179 route product structure diagram
    ACSLDB1792088570-59-4
Inquiry

2. ACSLDB179 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLBZA486 route compound structure diagram
    ACLBZA4861285533-08-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLDB179 route product structure diagram
    ACSLDB1792088570-59-4
Inquiry

Comments (0)